Abstract
This study investigates the adverse reactions associated with intravenous (IV) injections of ivermectin in camels (Camelus dromedarius) presented to a veterinary clinic in Algatroun city. A total of 45 camels were divided into four groups and treated with 1% ivermectin via intravenous (IV) and subcutaneous (SC) routes. Group 1 consisted of three young camels administered 15 ml of ivermectin IV, while Groups 2, 3, and 4 included camels treated SC with doses of 5 ml, 10 ml, and 20 ml, respectively. Clinical signs of toxicity, including hypersalivation, ataxia, depression, and coma, were observed mainly in the IV group, with significant adverse effects noted at doses exceeding 7.5 times the recommended dosage. The study highlights the rapid onset of severe toxicity in young camels, with fatalities occurring within hours of administration. Treatments involving dexamethasone, isotonic solutions, and multivitamins showed beneficial effects in mitigating toxicity. This research stresses the critical importance of adhering to recommended dosing guidelines and the risks associated with improper administration practices by non-veterinarians